focus -WSS

focus

author：entertainment 2025-09-27 09:46:58 - browse：421

Sen. Rand Paul (C) (R-KY) questions Homeland Security Secretary Alejandro Mayorkas and FBI Director Christopher Wray during a hearing held by the Senate Homeland Security and Governmental Affairs Committee October 31, 2023 in Washington, DC. — Sen. Rand Paul (R-Ky.) Win McNamee/Getty Images

WASHINGTON — A Senate panel Wednesday passed a bill aimed at preventing certain Chinese companies from doing business in the United States. The sole no vote was by Sen. Rand Paul (R-Ky.), who worries that Congress is using anger toward China as a cover for advancing parochial interests.

Many in Congress are worried the Chinese government and military are using the rising dominance of national companies to gather Americans’ genetic information, which could be used for reasons that range from creating bioweapons to giving China a leg up in drug development.

The Biosecure Act, by Homeland Security and Governmental Affairs Chair Gary Peters (D-Mich.), is a response to those concerns. The bill would block the U.S. government from contracting with companies that do business with Chinese “biotechnology companies of concern,” and it names four companies that must be on that list: BGI Genomics, MGI, Complete Genomics, WuXi AppTec, and any subsidiary, parent affiliate, or successor of these companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Physician subsidies by hospitals soar in wake of No Surprises Act

entertainment

explore

WSS

Traditional Chinese medicine benefits explored in new JAMA study

Hospitals warn Medicare's drug payment fix is ‘unlawful’

First Opinion Podcast: How to protect health care in times of war

Why Sanofi got shellacked over its spinoff

Biden's order seeks to regulate AI risk without stifling innovation

CDC recommends rationing of RSV shot due to shortages

Wikipedia

focus

Wikipedia

United colonoscopy coverage change 'may cost lives,' doctors say

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Wildfire smoke exposes gaps in outdoor worker protections

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout Newsletter: What happened with Sarepta's Duchenne data

Malaria cases in Florida and Texas: Here’s what you need to know

Why Sanofi got shellacked over its spinoff

Hollywood unions extend contract negotiations for actors

First Opinion Podcast: How to protect health care in times of war

explore

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Meta's Zuckerberg and Chan on track to put $50 billion into science

Medtronic CEO on promising devices for diabetes, hypertension

Senate panel to vote on hospitals, PBMs, prisoner care

Medtronic CEO on promising devices for diabetes, hypertension

Physician subsidies by hospitals soar in wake of No Surprises Act

entertainment

focus

explore

knowledge